Clinical Outcome after Intra-Arterial Stroke Therapy in the Very Elderly: Why is it so Heterogeneous?

RV Chandra. Very elderly patients (i.e., ≥80 years) are disproportionally affected by stroke. In the future, invasive techniques for collateral augmentation may be benefit. As selection criteria for IAT in the elderly are refined, and with more rapid and

Clinical Outcome after Intra-Arterial Stroke Therapy in the Very Elderly: Why is it so Heterogeneous? https://t.co/j3DR1sjYK9

Clinical Outcome after Intra-Arterial Stroke Therapy in the Very Elderly: Why is it so Heterogeneou... http://t.co/GP8dm7rJMS #Neurology